Navigation Links
Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer
Date:7/13/2011

ce from PAF, patients and physicians should contact their Co-Pay Relief Program by visiting www.copays.org or calling toll free (866) 512-3681.

Lilly Oncology has a tradition of supporting patients who cannot afford crucial medicines, with donations of cancer treatments valued at more than $16.3 million in 2010. PatientOne is a program that addresses financial and coverage issues for uninsured, insured, and underinsured patients who are candidates for Lilly oncology products. PatientOne supported more than 1,600 patients in 2010 and has recently expanded its eligibility requirements to include households with income up to 500 percent of the federal poverty level. To learn more about PatientOne, please visit www.LillyPatientOne.com.

About Non-Small Cell Lung Cancer (NSCLC)

Globally, lung cancer is the most common form of cancer and the biggest killer, causing 1.3 million cancer deaths annually.(1) About 85 – 90 percent of all lung cancers are NSCLC.(2)  The liver, bones and brain are potential targets if the cancerous cells enter the bloodstream.

NSCLC comprises a group of histologies or tumor types differentiated by cellular structure. Nonsquamous histology includes adenocarcinoma and large cell carcinoma, which account for more than half of all NSCLC diagnoses(3), as well as histologies classified as "other."

About Lilly Oncology

For more than four decades, Lilly Oncology, a division of Eli Lilly and Company, has been dedicated to delivering innovative solutions that improve the care of people living with cancer.  Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. To learn more about Lilly's commitment to cancer, please visit www.LillyOncology.com.  

About Eli Lilly and Company


'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
2. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
3. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
4. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
5. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
6. Lilly Declares Third-Quarter 2011 Dividend
7. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
8. Synthes and Lilly Sign Development and Collaboration Agreement
9. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
10. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
11. Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... and segments the concerned market with analysis and ... $261.8 million in 2014, and is estimated to ... of 19.3% from 2014 to 2019. ... Simulation Market for an analysis of industry trends ...
(Date:6/2/2015)... , June 2, 2015 BioDelivery Sciences International, Inc. ... the presentation by Dr. Mark A. Sirgo , President ... 2:30 PM Eastern time. Jefferies 2015 Global Healthcare ... Hyatt, New York City , NY ... accessed at www.bdsi.com .  For those who are not ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ANT Wireless, ... the market entry of two new products implementing the ... Trainer announce new wireless interoperability in their bike trainer ... for cyclists. Tacx has implemented the FE-C device profile ... as well as its new indoor training software, while ...
(Date:6/2/2015)... MAP Health Management, LLC, a provider of outcome data, ... facilities, announced today that Jared Smith has joined the ... be responsible for developing and implementing a marketing strategy ... message, products and initiatives. , Prior to joining MAP, ... in Irving, Texas, where he was responsible for developing ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 DiaTech ... drug response profiling test to help oncologists provide ... College of American Pathologists (CAP) for its laboratories ... CAP certification is equivalent to the ‘Good Housekeeping’ ... and chief executive officer for DiaTech. “It’s a ...
(Date:6/2/2015)... 2015 For those that have ever ... to harmful germs, chemicals and bodily fluids from each ... an inventor from Queens Village, N.Y., their worries are ... efficient, fun, hygienic way to store and dispense toothpaste. ... bugs, chemicals and germs. Furthermore, it insures that all ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2
... GE Healthcare, the leading manufacturer of 3D/4D ultrasound ... Virginia Medical School (EVMS) obstetrician that can automate the ... fetal heart defects. GE Healthcare has licensed the software ... Alfred Abuhamad, M.D., chairman of obstetrics and gynecology at ...
... Communication and Compliance Important for Addressing ... Challenges Uncovered in Survey, AVENTURA, Fla., ... (UC) consider feeling unwell to be a,normal part of life, while ... UC patients, according to results from a,nationwide series of surveys presented ...
... First Oral Pharmacologic Agent Developed for the Treatment of Premature ... ... 7 Janssen-Cilag companies in,Europe have submitted a Marketing Authorisation Application ... years,of age., Premature ejaculation is a form of male sexual ...
... more than half, CDC study finds , FRIDAY, Dec. ... receiving the pneumococcal vaccine appears to be associated with ... to a new report from the U.S. Centers for ... 7-valent pneumococcal conjugate vaccine (PDV7) became part of the ...
... battle in fighting heart disease, ... Health Corp. CEO Gary Stanton., MELBOURNE, Fla., Dec. 7 ... heart disease all,in one Natural product. Lowering unhealthy cholesterol levels is ... build up of,plaque in the arteries and the heart muscle itself. ...
... AstraZeneca,CEO, and senior management from AstraZeneca (LSE: AZN) ... the biologics field, R&D and portfolio,progress plus the ... are available now on http://www.cantos.com ., ... do is register at, http://www.cantos.com ., Cantos.com ...
Cached Medicine News:Health News:Procedure to detect fetal heart defects is first automated use of 3-D ultrasound 2Health News:Procedure to detect fetal heart defects is first automated use of 3-D ultrasound 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 4Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 5Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 6Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 7Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 8Health News:Submission of Marketing Authorisation Application for Dapoxetine in Europe 2Health News:Pneumonia Vaccine Is Keeping Kids Healthier 2Health News:New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: